GNLX vs. TARA

Last updated Aug 1, 2026

GNLX (Genelux Corporation) and TARA (Protara Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, GNLX returned -47.66%/yr vs 16.02%/yr for TARA. Their 0.15 correlation means their historical movements had little consistent relationship.

Performance

GNLX vs. TARA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Genelux Corporation (GNLX) and Protara Therapeutics, Inc. (TARA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, GNLX achieves a -32.57% return, which is significantly lower than TARA's -26.45% return.

GNLX

• 1D: -3.61%
• 1M: -1.67%
• 6M: 10.53%
• YTD: -32.57%
• 1Y: -16.24%
• 3Y*: -47.66%
• 5Y*: —
• 10Y*: —
• ALL TIME*: -18.39%

TARA

• 1D: -2.73%
• 1M: -3.45%
• 6M: -44.63%
• YTD: -26.45%
• 1Y: 28.10%
• 3Y*: 16.02%
• 5Y*: -13.14%
• 10Y*: -35.66%
• ALL TIME*: -33.19%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
GNLX Genelux Corporation	$464.51K	$480.88K	$518.22K
TARA Protara Therapeutics, Inc.	$1.58M	$2.01M	$3.09M

GNLX vs. TARA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
GNLX Genelux Corporation	-32.57%	84.75%	-83.15%	133.50%
TARA Protara Therapeutics, Inc.	-26.45%	0.95%	181.58%	-42.05%

Correlation

The correlation between GNLX and TARA is 0.23, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.23
Correlation (3Y) Balances recent behavior with more history.	0.16
Correlation (All Time) Calculated using the full available price history since Jan 26, 2023	0.15

Fundamentals

Market Cap GNLX : $131.83M TARA : $220.32M
EPS GNLX : -$0.85 TARA : -$1.30
PB Ratio GNLX : 5.66 TARA : 1.24
Total Revenue (TTM) GNLX : $8.00K TARA : $0.00
Gross Profit (TTM) GNLX : -$283.00K TARA : -$181.00K
EBITDA (TTM) GNLX : -$24.96M TARA : -$66.86M

Return for Risk

GNLX vs. TARA — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

GNLX

GNLX Risk / Return Rank: 40
GNLX Sharpe Ratio Rank: 37
GNLX Sortino Ratio Rank: 42
GNLX Omega Ratio Rank: 43
GNLX Calmar Ratio Rank: 38
GNLX Martin Ratio Rank: 39

TARA

TARA Risk / Return Rank: 58
TARA Sharpe Ratio Rank: 57
TARA Sortino Ratio Rank: 61
TARA Omega Ratio Rank: 61
TARA Calmar Ratio Rank: 57
TARA Martin Ratio Rank: 56

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

GNLX vs. TARA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Genelux Corporation (GNLX) and Protara Therapeutics, Inc. (TARA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	GNLX	TARA	Difference
Sharpe ratio: Return per unit of total volatility	-0.17	0.34	-0.50
Sortino ratio: Return per unit of downside risk	0.33	1.08	-0.75
Omega ratio: Gain probability vs. loss probability	1.05	1.14	-0.09
Calmar ratio: Return relative to maximum drawdown	-0.18	0.51	-0.70
Martin ratio: Return relative to average drawdown	-0.25	0.97	-1.22

GNLX vs. TARA - Sharpe Ratio Comparison

The current GNLX Sharpe Ratio is -0.17, which is lower than the TARA Sharpe Ratio of 0.34. The chart below compares the historical Sharpe Ratios of GNLX and TARA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

GNLX vs. TARA - Drawdown Comparison

The maximum GNLX drawdown since its inception was -95.74%, roughly equal to the maximum TARA drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for GNLX and TARA.

Drawdown Indicators

	GNLX	TARA	Difference
Max Drawdown Largest peak-to-trough decline	-95.74%	-99.86%	+4.12%
Max Drawdown (1Y) Largest decline over 1 year	-72.09%	-51.72%	-20.37%
Max Drawdown (3Y) Largest decline over 3 years	-94.60%	-66.46%	-28.14%
Max Drawdown (5Y) Largest decline over 5 years	—	-86.59%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-99.75%	—
Current Drawdown Current decline from peak	-92.26%	-99.51%	+7.25%
Average Drawdown Average peak-to-trough decline	-73.91%	-85.39%	+11.48%
Ulcer Index Depth and duration of drawdowns from previous peaks	52.79%	27.36%	+25.43%

Volatility

GNLX vs. TARA - Volatility Comparison

Genelux Corporation (GNLX) has a higher volatility of 12.26% compared to Protara Therapeutics, Inc. (TARA) at 11.42%. This indicates that GNLX's price experiences larger fluctuations and is considered to be riskier than TARA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GNLX	TARA	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.26%	11.42%	+0.84%
Volatility (6M) Calculated over the trailing 6-month period	40.54%	50.70%	-10.16%
Volatility (1Y) Calculated over the trailing 1-year period	80.79%	78.61%	+2.18%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	108.76%	81.03%	+27.73%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	108.76%	91.12%	+17.64%

Dividends

GNLX vs. TARA - Dividend Comparison

Neither GNLX nor TARA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both GNLX and TARA in my portfolio?

GNLX and TARA have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, GNLX or TARA?

GNLX has higher volatility (12.26%) compared to TARA (11.42%). In terms of maximum drawdown, GNLX dropped -95.74% vs TARA's -99.86%.

Which has better risk-adjusted returns?

TARA currently has the higher Sharpe Ratio (0.34 vs -0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.